Literature DB >> 27816941

The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise Algorithm.

Konstantinos N Fountoulakis1, Lakshmi Yatham1, Heinz Grunze1, Eduard Vieta1, Allan Young1, Pierre Blier1, Siegfried Kasper1, Hans Jurgen Moeller1.   

Abstract

Background: The current paper includes a systematic search of the literature, a detailed presentation of the results, and a grading of treatment options in terms of efficacy and tolerability/safety. Material and
Methods: The PRISMA method was used in the literature search with the combination of the words 'bipolar,' 'manic,' 'mania,' 'manic depression,' and 'manic depressive' with 'randomized,' and 'algorithms' with 'mania,' 'manic,' 'bipolar,' 'manic-depressive,' or 'manic depression.' Relevant web pages and review articles were also reviewed.
Results: The current report is based on the analysis of 57 guideline papers and 531 published papers related to RCTs, reviews, posthoc, or meta-analysis papers to March 25, 2016. The specific treatment options for acute mania, mixed episodes, acute bipolar depression, maintenance phase, psychotic and mixed features, anxiety, and rapid cycling were evaluated with regards to efficacy. Existing treatment guidelines were also reviewed. Finally, Tables reflecting efficacy and recommendation levels were created that led to the development of a precise algorithm that still has to prove its feasibility in everyday clinical practice. Conclusions: A systematic literature search was conducted on the pharmacological treatment of bipolar disorder to identify all relevant random controlled trials pertaining to all aspects of bipolar disorder and graded the data according to a predetermined method to develop a precise treatment algorithm for management of various phases of bipolar disorder. It is important to note that the some of the recommendations in the treatment algorithm were based on the secondary outcome data from posthoc analyses.
© The Author 2016. Published by Oxford University Press on behalf of CINP.

Entities:  

Keywords:  anticonvulsants; antidepressants; antipsychotics; bipolar depression; bipolar disorder; clinical trials; evidence-based guidelines; lithium; mania; mood stabilizers; treatment

Mesh:

Substances:

Year:  2017        PMID: 27816941      PMCID: PMC5409012          DOI: 10.1093/ijnp/pyw100

Source DB:  PubMed          Journal:  Int J Neuropsychopharmacol        ISSN: 1461-1457            Impact factor:   5.176


  711 in total

Review 1.  Acute bipolar mania: a systematic review and meta-analysis of co-therapy vs. monotherapy.

Authors:  L A Smith; V Cornelius; A Warnock; M J Tacchi; D Taylor
Journal:  Acta Psychiatr Scand       Date:  2007-01       Impact factor: 6.392

2.  Double-blind, randomized, placebo-controlled trials of ethyl-eicosapentanoate in the treatment of bipolar depression and rapid cycling bipolar disorder.

Authors:  Paul E Keck; Jim Mintz; Susan L McElroy; Marlene P Freeman; Trisha Suppes; Mark A Frye; Lori L Altshuler; Ralph Kupka; Willem A Nolen; Gabriele S Leverich; Kirk D Denicoff; Heinz Grunze; Naihua Duan; Robert M Post
Journal:  Biol Psychiatry       Date:  2006-06-30       Impact factor: 13.382

Review 3.  Report of the Texas Consensus Conference Panel on medication treatment of bipolar disorder 2000.

Authors:  Trisha Suppes; Ellen B Dennehy; Alan C Swann; Charles L Bowden; Joseph R Calabrese; Robert M A Hirschfeld; Paul E Keck; Gary S Sachs; M Lynn Crismon; Marcia G Toprac; Steven P Shon
Journal:  J Clin Psychiatry       Date:  2002-04       Impact factor: 4.384

4.  The effectiveness of cognitive behavioral group therapy in treating bipolar disorder: a randomized controlled study.

Authors:  Rafael Thomaz da Costa; Elie Cheniaux; Pedro Augusto Legnani Rosaes; Marcele Regine de Carvalho; Rafael Christophe da Rocha Freire; Márcio Versiani; Bernard Pimentel Rangé; Antonio Egidio Nardi
Journal:  Braz J Psychiatry       Date:  2011-06       Impact factor: 2.697

5.  Cariprazine in the treatment of acute mania in bipolar I disorder: a double-blind, placebo-controlled, phase III trial.

Authors:  Gary S Sachs; William M Greenberg; Anju Starace; Kaifeng Lu; Adam Ruth; István Laszlovszky; György Németh; Suresh Durgam
Journal:  J Affect Disord       Date:  2014-11-24       Impact factor: 4.839

6.  Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine.

Authors:  Mauricio Tohen; Joseph R Calabrese; Gary S Sachs; Michael D Banov; Holland C Detke; Richard Risser; Robert W Baker; James C-Y Chou; Charles L Bowden
Journal:  Am J Psychiatry       Date:  2006-02       Impact factor: 18.112

Review 7.  Is anticonvulsant treatment of mania a class effect? Data from randomized clinical trials.

Authors:  A R Rosa; K Fountoulakis; M Siamouli; X Gonda; E Vieta
Journal:  CNS Neurosci Ther       Date:  2009-12-15       Impact factor: 5.243

Review 8.  The contemporary face of bipolar illness: complex diagnostic and therapeutic challenges.

Authors:  Konstantinos N Fountoulakis
Journal:  CNS Spectr       Date:  2008-09       Impact factor: 3.790

9.  Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression.

Authors:  Mauricio Tohen; Eduard Vieta; Joseph Calabrese; Terence A Ketter; Gary Sachs; Charles Bowden; Philip B Mitchell; Franca Centorrino; Richard Risser; Robert W Baker; Angela R Evans; Karin Beymer; Sanjay Dube; Gary D Tollefson; Alan Breier
Journal:  Arch Gen Psychiatry       Date:  2003-11

10.  A preliminary double-blind study on the efficacy of carbamazepine in prophylaxis of manic-depressive illness.

Authors:  T Okuma; K Inanaga; S Otsuki; K Sarai; R Takahashi; H Hazama; A Mori; S Watanabe
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

View more
  27 in total

Review 1.  Treatment of Bipolar Disorder in a Lifetime Perspective: Is Lithium Still the Best Choice?

Authors:  Gabriele Sani; Giulio Perugi; Leonardo Tondo
Journal:  Clin Drug Investig       Date:  2017-08       Impact factor: 2.859

2.  Next-Step Treatment Considerations for Patients With Treatment-Resistant Depression That Responds to Low-Dose Intravenous Ketamine.

Authors:  William V Bobo; Patricio Riva-Posse; Fernando S Goes; Sagar V Parikh
Journal:  Focus (Am Psychiatr Publ)       Date:  2020-04-23

3.  Genetic Variations Associated with Long-Term Treatment Response in Bipolar Depression.

Authors:  Gerard Anmella; Silvia Vilches; Jordi Espadaler-Mazo; Andrea Murru; Isabella Pacchiarotti; Miquel Tuson; Marina Garriga; Eva Solé; Mercè Brat; Giovanna Fico; Eduard Vieta
Journal:  Genes (Basel)       Date:  2021-08-18       Impact factor: 4.096

Review 4.  Lithium treatment of Bipolar disorder in adults: A systematic review of randomized trials and meta-analyses.

Authors:  Konstantinos N Fountoulakis; Mauricio Tohen; Carlos A Zarate
Journal:  Eur Neuropsychopharmacol       Date:  2022-01       Impact factor: 4.600

5. 

Authors:  Marta H Costa; Mauricio Kunz; Andrew A Nierenberg; Thilo Deckersbach; Michael Berk; Pedro V S Magalhaes
Journal:  Can J Psychiatry       Date:  2020-01-21       Impact factor: 4.356

6.  Preventing Suicide among Psychiatric Inpatients with Psychotic Depression.

Authors:  Kristin J Fredriksen; Margrethe A Schaufel; Jan O Johannessen; Fredrik A Walby; Larry Davidson; Helle K Schoeyen
Journal:  Psychiatr Q       Date:  2020-03

Review 7.  Bipolar Disorder and Obesity: Contributing Factors, Impact on Clinical Course, and the Role of Bariatric Surgery.

Authors:  Noreen A Reilly-Harrington; Emily H Feig; Jeff C Huffman
Journal:  Curr Obes Rep       Date:  2018-12

Review 8.  Electroconvulsive Therapy and Movement Disorders. New Perspectives on A Time-Tested Therapy.

Authors:  Pedro J Garcia Ruiz
Journal:  Mov Disord Clin Pract       Date:  2021-03-09

9.  Efficacy and tolerability of atypical antipsychotics for acute bipolar depression: a network meta-analysis.

Authors:  Aditi Kadakia; Carole Dembek; Vincent Heller; Rajpal Singh; Jennifer Uyei; Katsuhiko Hagi; Tadashi Nosaka; Antony Loebel
Journal:  BMC Psychiatry       Date:  2021-05-11       Impact factor: 3.630

10.  Systemic challenges in bipolar disorder management: A patient-centered approach.

Authors:  Anastasiya Nestsiarovich; Nathaniel G Hurwitz; Stuart J Nelson; Annette S Crisanti; Berit Kerner; Matt J Kuntz; Alicia N Smith; Emma Volesky; Quentin L Schroeter; Jason L DeShaw; S Stanley Young; Robert L Obenchain; Ronald L Krall; Kimmie Jordan; Jan Fawcett; Mauricio Tohen; Douglas J Perkins; Christophe G Lambert
Journal:  Bipolar Disord       Date:  2017-09-13       Impact factor: 6.744

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.